Eli Lilly (LLY) stock
NYSE
As of the Nov 5, 2026 close (U.S. Eastern)
Events and reference metrics · 1
- Market cap
- $1.28T
- As of Nov 5, 2026
- P/E
- 46.56x
- Trailing twelve months
- P/B
- 31.89x
- Latest reported equity
- P/S
- 14.85x
- Trailing twelve months
- ROE
- 68.5%
- Trailing twelve months
- Dividend yield
- 0.46%
- Latest fiscal-year dividends
Multiples use the price as of Nov 5, 2026 and may differ from the current price.
- Market cap
- $1.28T
- As of Nov 5, 2026
- P/E
- 46.56x
- Trailing twelve months
- P/B
- 31.89x
- Latest reported equity
- P/S
- 14.85x
- Trailing twelve months
- ROE
- 68.5%
- Trailing twelve months
- Dividend yield
- 0.46%
- Latest fiscal-year dividends
Multiples use the price as of Nov 5, 2026 and may differ from the current price.
Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.
Price date for the multiples · Nov 5, 2026 · Financial period · Trailing twelve months
P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock
P/E
46.56x
P/B
31.89x
P/S
14.85x
Earnings and dividend metrics▾
Earnings
EPS
$29.31
Earnings per share
BPS
$42.80
Book value per share
ROE
68.5%
Return on equity
- EPS — what one share earned over the last four quarters. This company earned $29.31 per share.
- BPS — net assets divided by the number of shares. Each share is backed by $42.80 of net assets.
- ROE — how much the company earned on shareholder equity over a year: 68.5%.
Dividends
Yield
0.46%
Dividend per share
$6.23
Payout ratio
19.5%
Consecutive years
10+ yrs
Yield uses fiscal 2025 dividends · Dividend per share and payout ratio are for fiscal 2025.
- Dividend yield — dividends divided by the share price (or market cap). It falls when the price rises.
- Dividend per share — the fiscal-year dividend per share. For one hundred shares that is about $623.00 before tax.
- Payout ratio — 19.5% of earnings was paid out as dividends.
- Consecutive years — dividends were paid every year for more than 10 years. That does not mean they will continue.
Reference only · not a promise of future dividends
ⓘ What are these valuation metrics?▾
P/E = share price ÷ earnings per share (EPS)
P/B = share price ÷ book value per share (BPS)
P/S = share price ÷ sales per share
P/E shows how many times annual earnings per share the price is; not all earnings are paid to shareholders. P/B compares the price with net assets, and P/S with sales.
Higher or lower is not good or bad by itself. Typical levels differ by industry; read P/B alongside ROE and P/S alongside margins.
ChickenStock computes these from SEC financial filings: net income and revenue are summed over the latest four quarters, and equity is the latest reported balance.
A negative P/E means a net loss. Reference information only, not a recommendation to buy or sell.
Latest earnings
SEC filingsJul–Sep 2026(FY2026 Q3)
Revenue increased 38.6% from the same period a year earlier.
Key reported figures come first. Select one to see the same quarter across three years.
Revenue · same quarter, three years
Year-ago quarter $17.6B+38.6%
$11.4B
Jul–Sep '24
$17.6B
Jul–Sep '25
$24.4B
Jul–Sep '26
The next earnings date has not been confirmed yet.
ⓘ Notes on these figures▾
- Results for Jul–Sep 2026 are from the 10-Q submitted to SEC EDGAR on Oct 29, 2026.
- Earnings per share increased 16.3% from the same quarter a year earlier.
- Revenue increased 38.6% from the same quarter a year earlier.
- Net income increased 15.5% from the same quarter a year earlier.
Filed Oct 29, 2026 · 10-Q · SEC EDGAR · View original
Reported results are from SEC EDGAR filings. Reference information only, not investment advice.
Insider transactions
Recent Form 4 filings grouped by person, date and transaction type.
- Ricks David APresident, Chair, and CEO · Nov 3, 2026Gift23,538 shares · $0Avg. price $0555,278 shares held after
- Hakim AnatEVP, GC & Secretary · Nov 2, 2026Open-market sale5,000 shares · $7.0MAvg. price $1,402.524,137 shares held after
- Skovronsky DanielEVP, CS&PO & Pres. LRL · Nov 2, 2026Gift119 shares · $0Avg. price $0159,953 shares held after
- Custer Kenneth L.EVP & President, Card Met Hlth · Nov 1, 2026Shares withheld for taxes1,425 shares · $2.0MAvg. price $1,417.5411,935 shares held after
- Hernandez EdgardoEVP & Pres., Mfg. Operations · Nov 1, 2026Shares withheld for taxes1,123 shares · $1.6MAvg. price $1,417.5447,490 shares held after
- Brown Adrienne SEVP, President LLY Imm · Nov 1, 2026Shares withheld for taxes1,099 shares · $1.6MAvg. price $1,417.549,894 shares held after
- Dozier EricEVP, Chief People Officer · Nov 1, 2026Shares withheld for taxes1,019 shares · $1.4MAvg. price $1,417.5415,520 shares held after
- Montarce LucasEVP & CFO · Nov 1, 2026Shares withheld for taxes678 shares · $961KAvg. price $1,417.5417,191 shares held after
- Montarce LucasEVP & CFO · Nov 1, 2026Option exercise1,610 shares · $0Avg. price $017,868 shares held after
- Brown Adrienne SEVP, President LLY Imm · Nov 1, 2026Option exercise2,530 shares · $0Avg. price $010,993 shares held after
- Custer Kenneth L.EVP & President, Card Met Hlth · Nov 1, 2026Option exercise3,220 shares · $0Avg. price $013,361 shares held after
- Dozier EricEVP, Chief People Officer · Nov 1, 2026Option exercise2,300 shares · $0Avg. price $016,539 shares held after
- Hernandez EdgardoEVP & Pres., Mfg. Operations · Nov 1, 2026Option exercise2,530 shares · $0Avg. price $048,613 shares held after
- LUCIANO JUAN RDirector · Oct 19, 2026Grant or award13 shares · $16KAvg. price $1,240.339816,970 shares held after
- Alvarez RalphDirector · Oct 19, 2026Grant or award10 shares · $12KAvg. price $1,240.339855,848 shares held after
- Fyrwald J ErikDirector · Oct 19, 2026Grant or award8 shares · $10KAvg. price $1,240.339775,544 shares held after
- Sulzberger GabrielleDirector · Oct 19, 2026Grant or award4 shares · $5KAvg. price $1,240.33923,016 shares held after
- LUCIANO JUAN RDirector · Sep 21, 2026Grant or award14 shares · $16KAvg. price $1,164.890216,957 shares held after
- Alvarez RalphDirector · Sep 21, 2026Grant or award11 shares · $12KAvg. price $1,164.890155,838 shares held after
- Fyrwald J ErikDirector · Sep 21, 2026Grant or award9 shares · $10KAvg. price $1,164.890275,536 shares held after
- Sulzberger GabrielleDirector · Sep 21, 2026Grant or award4 shares · $5KAvg. price $1,164.8893,012 shares held after
- Seymour MelissaEVP, Global Quality · Sep 9, 2026Gift12 shares · $0Avg. price $01,038 shares held after
- Dozier EricEVP, Chief People Officer · Sep 2, 2026Gift216 shares · $0Avg. price $014,239 shares held after
- Hernandez EdgardoEVP & Pres., Mfg. Operations · Sep 2, 2026Gift13 shares · $0Avg. price $046,083 shares held after
- Jonsson PatrikEVP & President, LLY Int'l · Aug 17, 2026Open-market sale6,500 shares · $7.6MAvg. price $1,175.154,147 shares held after
- LUCIANO JUAN RDirector · Aug 17, 2026Grant or award13 shares · $16KAvg. price $1,183.160316,918 shares held after
- Alvarez RalphDirector · Aug 17, 2026Grant or award10 shares · $12KAvg. price $1,183.159855,745 shares held after
- Fyrwald J ErikDirector · Aug 17, 2026Grant or award8 shares · $10KAvg. price $1,183.160575,418 shares held after
- Sulzberger GabrielleDirector · Aug 17, 2026Grant or award4 shares · $5KAvg. price $1,183.16073,004 shares held after
- Zakrowski Donald ASVP, Finance, & CAO · Aug 10, 2026Open-market sale2,000 shares · $2.4MAvg. price $1,185.011,526 shares held after
- Hakim AnatEVP, GC & Secretary · Aug 7, 2026Open-market sale5,000 shares · $6.0MAvg. price $1,19011,875 shares held after
- Seymour MelissaEVP, Global Quality · Aug 1, 2026Shares withheld for taxes439 shares · $504KAvg. price $1,148.841,067 shares held after
- Seymour MelissaEVP, Global Quality · Aug 1, 2026Option exercise981 shares · $0Avg. price $01,506 shares held after
- LUCIANO JUAN RDirector · Jul 20, 2026Grant or award14 shares · $16KAvg. price $1,146.900116,905 shares held after
- Alvarez RalphDirector · Jul 20, 2026Grant or award11 shares · $12KAvg. price $1,146.899755,734 shares held after
- Fyrwald J ErikDirector · Jul 20, 2026Grant or award9 shares · $10KAvg. price $1,146.899975,410 shares held after
- Sulzberger GabrielleDirector · Jul 20, 2026Grant or award4 shares · $5KAvg. price $1,146.90043,000 shares held after
- Seymour MelissaEVP, Global Quality · Sep 22, 2025Gift17 shares · $0Avg. price $01,050 shares held after
Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.
Recent SEC filings
40 filingsRecent filing summaries
Newest first by publication date · may differ from the filing date
- AI summary10-QThe company said revenue rose for the 3- and 9-month periods ended September 30, 2026, driven mainly by higher volume, which was partly offset by lower realized prices. It said the higher volume and lower prices were mainly driven by Mounjaro and Zepbound.Published Oct 29, 2026 · Filed Oct 29, 2026Read the summary →
- AI summary8-KThe company said revenue for Q3 2026 rose to $24,397 million, up 39% from $17,601 million a year earlier. It cited a 53% increase in volume, partly offset by a 15% decline in realized prices.Published Oct 29, 2026 · Filed Oct 29, 2026Read the summary →
- AI summary8-KEli Lilly said on November 18, 2025 its Board of Directors elected Carolyn R. Bertozzi, Ph.D. as a new member of the Board, effective December 8, 2025.Published Oct 12, 2026 · Filed Nov 21, 2025Read the summary →
- The company said revenue rose for the 3- and 9-month periods ended September 30, 2026, driven mainly by higher volume, which was partly offset by lower realized prices. It said the higher volume and lower prices were mainly driven by Mounjaro and Zepbound.Read the full analysis →
- The company said revenue for Q3 2026 rose to $24,397 million, up 39% from $17,601 million a year earlier. It cited a 53% increase in volume, partly offset by a 15% decline in realized prices.Read the full analysis →
Filings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.
Company overview
Expand ▾
Eli Lilly (LLY) stock information
NYSE
Eli Lilly (LLY) is listed on NYSE. Its market capitalization is about $1.28T. On trailing-twelve-month earnings the P/E ratio is 46.56, and the P/B ratio is 31.89. Return on equity is 68.5%. These figures are computed in-house from official filings and are reference information only.
Eli Lilly — frequently asked questions
- What is the P/E ratio of Eli Lilly (LLY)?
- On a trailing-twelve-month basis, LLY trades at a P/E ratio of 46.56. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
- What is the market capitalization of Eli Lilly?
- LLY has a market capitalization of about $1.28T. The figure moves with the share price and is refreshed each trading day.
- Does Eli Lilly pay a dividend?
- LLY has a dividend yield of about 0.46%, based on disclosed payment history. Dividend policy can change; this is reference information only.
- Is this page investment advice?
- No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.
All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.